Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 53801-53850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05868135
Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
N/ARecruiting
800 participants
Started: Sep 9, 2021 · Completed: Dec 31, 2027
3 conditions4 sponsors4 locations
NCT04914507
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
NARecruiting
106 participants
Started: Sep 9, 2021 · Completed: Sep 30, 2029
1 condition1 sponsor12 locations
NCT05036629
Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects
NARecruiting
600 participants
Started: Sep 9, 2021 · Completed: Sep 8, 2026
3 conditions1 sponsor1 location
NCT04923841
Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine
NARecruiting
579 participants
Started: Sep 9, 2021 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT04968756
Evaluating the Safety of the SPECTRALIS CENTAURUS Device
NARecruiting
30 participants
Started: Sep 9, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05080322
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
PHASE4Recruiting
150 participants
Started: Sep 9, 2021 · Completed: Jan 1, 2025
1 condition4 sponsors1 location
NCT03694158
Investigating Dupilumab's Effect in Asthma by Genotype
PHASE4Recruiting
150 participants
Started: Sep 8, 2021 · Completed: Mar 31, 2027
1 condition6 sponsors6 locations
NCT06376604
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
NARecruiting
30 participants
Started: Sep 8, 2021 · Completed: Dec 30, 2025
4 conditions2 sponsors1 location
NCT06099912
Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM
N/ARecruiting
100 participants
Started: Sep 8, 2021 · Completed: Sep 8, 2029
2 conditions1 sponsor1 location
NCT04986423
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
200 participants
Started: Sep 8, 2021 · Completed: Jun 30, 2026
1 condition3 sponsors31 locations
NCT04937907
Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
PHASE2Recruiting
50 participants
Started: Sep 8, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05255042
Tissue Models for Liver Disease
N/ARecruiting
24 participants
Started: Sep 8, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05023434
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients with Brain Tumors
N/ARecruiting
60 participants
Started: Sep 8, 2021 · Completed: Oct 1, 2026
3 conditions1 sponsor1 location
NCT04890613
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
PHASE1Recruiting
52 participants
Started: Sep 8, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor8 locations
NCT04807296
Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP)
NARecruiting
100 participants
Started: Sep 8, 2021 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04098445
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
N/ARecruiting
2,000 participants
Started: Sep 8, 2021 · Completed: Sep 30, 2036
5 conditions1 sponsor9 locations
NCT04717427
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
N/ARecruiting
250 participants
Started: Sep 8, 2021 · Completed: Jun 30, 2025
1 condition9 sponsors8 locations
NCT05033990
SPIROMICS Study of Early COPD Progression (SOURCE)
N/ARecruiting
1,000 participants
Started: Sep 8, 2021 · Completed: Apr 30, 2026
1 condition18 sponsors14 locations
NCT05100693
Smart Removal for Congenital Diaphragmatic Hernia
NARecruiting
25 participants
Started: Sep 8, 2021 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT04998396
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
PHASE1/PHASE2Recruiting
26 participants
Started: Sep 8, 2021 · Completed: Oct 8, 2030
1 condition1 sponsor4 locations
NCT04670029
Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
PHASE3Recruiting
186 participants
Started: Sep 8, 2021 · Completed: Feb 28, 2029
1 condition1 sponsor5 locations
NCT05043571
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
PHASE1Recruiting
20 participants
Started: Sep 8, 2021 · Completed: Nov 1, 2026
7 conditions1 sponsor1 location
NCT05077137
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
PHASE1Recruiting
25 participants
Started: Sep 7, 2021 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT04934826
Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass
NARecruiting
40 participants
Started: Sep 7, 2021 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05862831
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors
PHASE1/PHASE2Recruiting
285 participants
Started: Sep 7, 2021 · Completed: Nov 15, 2025
1 condition1 sponsor2 locations
NCT05032326
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
PHASE3Recruiting
80 participants
Started: Sep 7, 2021 · Completed: Apr 1, 2025
1 condition1 sponsor12 locations
NCT06672497
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
N/ARecruiting
30 participants
Started: Sep 7, 2021 · Completed: Mar 31, 2026
3 conditions3 sponsors1 location
NCT04902807
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
N/ARecruiting
500 participants
Started: Sep 7, 2021 · Completed: Jun 30, 2026
20 conditions1 sponsor1 location
NCT04969731
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
PHASE3Recruiting
408 participants
Started: Sep 7, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04927780
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
PHASE3Recruiting
378 participants
Started: Sep 7, 2021 · Completed: Jul 31, 2029
3 conditions3 sponsors22 locations
NCT05358483
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
N/ARecruiting
1,000 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2046
1 condition1 sponsor1 location
NCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
PHASE1Recruiting
60 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
EARLY_PHASE1Recruiting
60 participants
Started: Sep 7, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04967989
Clarifying the Optimal Application of SLT Therapy Trial
PHASE3Recruiting
790 participants
Started: Sep 7, 2021 · Completed: Aug 31, 2027
1 condition3 sponsors29 locations
NCT05537909
Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses
NARecruiting
60 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor15 locations
NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
N/ARecruiting
2,020 participants
Started: Sep 7, 2021 · Completed: Aug 31, 2029
16 conditions1 sponsor57 locations
NCT04460235
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
PHASE4Recruiting
160 participants
Started: Sep 7, 2021 · Completed: Nov 30, 2027
3 conditions1 sponsor7 locations
NCT04933669
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
PHASE2Recruiting
122 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2029
3 conditions7 sponsors1 location
NCT04930393
Evaluating the Efficacy of PECS II Block Versus Axillary Ring Block in Rotator Cuff Repair Patients
NARecruiting
74 participants
Started: Sep 7, 2021 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT04934007
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
NARecruiting
136 participants
Started: Sep 6, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05023629
STunning After Balloon Occlusion
NARecruiting
50 participants
Started: Sep 6, 2021 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT05081037
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
NARecruiting
300 participants
Started: Sep 6, 2021 · Completed: May 26, 2026
3 conditions3 sponsors1 location
NCT05420493
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
PHASE1Recruiting
54 participants
Started: Sep 6, 2021 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT05552937
Evaluate the Safety and Efficacy of Tafasitamab Combined With Lenalidomide in Patients With Relapsed or Refractory DLBCL
PHASE2Recruiting
50 participants
Started: Sep 6, 2021 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05097261
Ketamine in Acute Brain Injury Patients.
PHASE4Recruiting
100 participants
Started: Sep 6, 2021 · Completed: Jun 30, 2026
1 condition7 sponsors8 locations
NCT05035108
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
EARLY_PHASE1Recruiting
10 participants
Started: Sep 5, 2021 · Completed: Nov 30, 2030
1 condition2 sponsors1 location
NCT05030337
Optimising Ventilation in Preterms With Closed-loop Oxygen Control
NARecruiting
70 participants
Started: Sep 5, 2021 · Completed: Mar 31, 2025
3 conditions2 sponsors1 location
NCT04770519
Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
N/ARecruiting
400 participants
Started: Sep 3, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05601999
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
PHASE3Recruiting
244 participants
Started: Sep 3, 2021 · Completed: Oct 31, 2024
1 condition1 sponsor11 locations
NCT04883437
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
PHASE2Recruiting
49 participants
Started: Sep 3, 2021 · Completed: Jan 15, 2026
8 conditions3 sponsors1 location